Procept Biorobotics Corp at Bank of America Healthcare Conference Transcript
I'm one of the med tech analysts here at BofA. And it's a pleasure to have PROCEPT BioRobotics with us today.
And from the company, Reza Zadno, CEO; and Kevin Waters, CFO. So thank you, guys.
So I guess I wanted to start with just kind of a quick review of Q1 and your guidance. You definitely gave some helpful color on the call and how to think about the cadence throughout the year. So maybe if you just want to start with a couple of highlights from the quarter, and then we'll talk in a little bit more detail about what you guys expect throughout the rest of the year.
So the highlight of the -- thanks for inviting us. Good to see you. For the quarter, we announced $14.2 million in Q1, and we increased the guidance for the year to 54 to 50 -- from $54 million to $58 million, we moved it to $58 million to $62 million.
And we are very happy to also have announced Aetna coming on board
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investorsā 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |